Development of an International Prostate Cancer Outcomes Registry

被引:35
作者
Evans, Sue M. [1 ]
Nag, Nupur [1 ]
Roder, David [2 ]
Brooks, Andrew [3 ]
Millar, Jeremy L. [4 ]
Moretti, Kim L. [2 ]
Pryor, David [5 ]
Skala, Marketa [6 ]
McNeil, John J. [1 ]
机构
[1] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[2] Univ S Australia, Ctr Populat Hlth Res, Adelaide, SA 5001, Australia
[3] Westmead Hosp, Dept Urol, Westmead, NSW 2145, Australia
[4] Alfred Hlth Radiat Oncol, Melbourne, Vic, Australia
[5] Princess Alexandra Hosp, Dept Radiat Oncol, Woolloongabba, Qld, Australia
[6] WP Holman Clin, Launceston, Tas, Australia
关键词
prostate cancer; clinical registry; population health; URBAN-RURAL DIFFERENCES; MEN; CARE; PATTERNS; QUALITY; SCALE; QUEENSLAND; VALIDATION; AUSTRALIA; MORTALITY;
D O I
10.1111/bju.13258
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives To establish a Prostate Cancer Outcomes Registry-Australia and New Zealand (PCOR-ANZ) for monitoring outcomes of prostate cancer treatment and care, in a cost-effective manner. Materials and Methods Stakeholders were recruited based on their interest, importance in achieving the monitoring and reporting of clinical practice and patient outcomes, and in amalgamation of existing registries. Each participating jurisdiction is responsible for local governance, site recruitment, data collection, and data transfer into the PCOR-ANZ. To establish each local registry, hospitals and clinicians within a jurisdiction were approached to voluntarily contribute to the registry following relevant ethical approval. Patient contact occurs following notification of prostate cancer through a hospital or pathology report, or from a cancer registry. Patient registration is based on an opt-out model. The PCOR-ANZ is a secure web-based registry adhering to ISO 27001 standards. Based on a standardised minimum data set, information on demographics, diagnosis, treatment, outcomes, and patient reported quality of life, are collected. Results Eight of nine jurisdictions have agreed to contribute to the PCOR-ANZ. Each jurisdiction has commenced implementation of necessary infrastructure to support rapid rollout. PCOR-ANZ has defined a minimum data set for collection, to enable analysis of key quality indicators that will aid in assessing clinical practice and patient focused outcomes. Conclusion PCOR-ANZ will provide a useful resource of risk-adjusted evidence-based data to clinicians, hospitals, and decision makers on prostate cancer clinical practice.
引用
收藏
页码:60 / 67
页数:8
相关论文
共 50 条
  • [31] Role, race, and place: Prostate cancer disparities in Patients' and Partners' health outcomes and psychosocial factors
    Song, Lixin
    Keyserling, Thomas C.
    Chen, Ronald C.
    Ma, Chunxuan
    Xu, Shenmeng
    Shieh, Karl
    Fuller, Gail P.
    Nielsen, Matthew E.
    Northouse, Laurel L.
    Tan, Xianming
    Rini, Christine
    [J]. CANCER MEDICINE, 2023, 12 (08): : 9857 - 9867
  • [32] Prostate cancer in Asia: design of a patient registry to inform real-world treatments, outcomes, and quality of life
    Liu, Yanfang
    Uemura, Hirotsugu
    Ye, Dingwei
    Lee, Ji Y.
    Chiong, Edmund
    Pu, Yeong-S
    Razack, Azad H. A.
    Pripatnanont, Choosak
    Rawal, Sudhir
    Low, Grace K. M.
    Qiu, Hong
    Chow, Weng H.
    Losio, Maximiliano Van Kooten
    [J]. PROSTATE INTERNATIONAL, 2019, 7 (03) : 108 - 113
  • [33] Obesity, race, and long-term prostate cancer outcomes
    Vidal, Adriana C.
    Oyekunle, Taofik
    Howard, Lauren E.
    De Hoedt, Amanda M.
    Kane, Christopher J.
    Terris, Martha K.
    Cooperberg, Matthew R.
    Amling, Christopher L.
    Klaassen, Zachary
    Freedland, Stephen J.
    Aronson, William J.
    [J]. CANCER, 2020, 126 (16) : 3733 - 3741
  • [34] Characteristics of Prostate Cancer Found at Fifth Screening in the European Randomized Study of Screening for Prostate Cancer Rotterdam: Can We Selectively Detect High-grade Prostate Cancer with Upfront Multivariable Risk Stratification and Magnetic Resonance Imaging?
    Alberts, Arnout R.
    Schoots, Ivo G.
    Bokhorst, Leonard P.
    Drost, Frank-Jan H.
    van Leenders, Geert J.
    Krestin, Gabriel P.
    Dwarkasing, Roy S.
    Barentsz, Jelle O.
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    [J]. EUROPEAN UROLOGY, 2018, 73 (03) : 343 - 350
  • [35] Marital status and prostate cancer outcomes
    Tyson, Mark D.
    Andrews, Paul E.
    Etzioni, David A.
    Ferrigni, Robert G.
    Humphreys, Mitchell R.
    Swanson, Scott K.
    Castle, Erik P.
    [J]. CANADIAN JOURNAL OF UROLOGY, 2013, 20 (02) : 6702 - 6706
  • [36] Prostate cancer outcomes and delays in care
    O'Callaghan, Michael E.
    Shi, Zumin
    Kopsaftis, Tina
    Moretti, Kim
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (03) : 449 - 455
  • [37] Decisional outcomes following use of an interactive web-based decision aid for prostate cancer screening
    Tomko, Catherine
    Davis, Kimberly
    Ludin, Samantha
    Kelly, Scott
    Stern, Aaron
    Luta, George
    Taylor, Kathryn L.
    [J]. TRANSLATIONAL BEHAVIORAL MEDICINE, 2015, 5 (02) : 189 - 197
  • [38] Outcomes of Expanded Use of PCA3 Testing in a Spanish Population with Clinical Suspicion of Prostate Cancer
    Rubio-Briones, J.
    Fernandez-Serra, A.
    Ramirez, M.
    Rubio, L.
    Collado, A.
    Casanova, J.
    Gomez-Ferrer, A.
    Ricos, J. V.
    Monros, J. L.
    Dumont, R.
    Ortiz, B.
    Iborra, I.
    Garcia-Casado, Z.
    Solsona, E.
    Lopez-Guerrero, J. A.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2011, 35 (10): : 589 - 596
  • [39] Survival outcomes in men with a positive family history of prostate cancer: a registry based study
    Ang, Mann
    Borg, Martin
    O'Callaghan, Michael E.
    [J]. BMC CANCER, 2020, 20 (01)
  • [40] Survival outcomes in men with a positive family history of prostate cancer: a registry based study
    Mann Ang
    Martin Borg
    Michael E. O’Callaghan
    [J]. BMC Cancer, 20